Vaccinate your immunocompromised patients!

To Vaccinate or Not to Vaccinate—opinion

I agree with Dr. Faro's concern about hepatitis B virus infection and his emphasis upon the hepatitis B vaccine. I would like to emphasize universal coverage, beyond the focus upon sexually active adolescents. This population should be cared for because of their high-risk sexual activity. However, they should not be our sole concern. Approximately half of our married population in their 20s and...

Norovirus in immunocompromised patients.

W hile undergoing a routine mammogram, Mrs. B, age 76 years and in good health, was found to have right axillary adenopathy. A core biopsy confirmed the diagnosis of follicular lymphoma and she was referred to an oncologist who recommended treatment with six cycles of bendamustine, mitoxantrone, and rituximab. She tolerated the treatment fairly well except for mild lower abdominal discomfort fo...

Vaccines in immunocompromised patients.

Etiologic Agents of Candidemia in Pediatric Immunocompromised Patients

Abstract Background: Candidemia is the main cause of fungal nosocomial bloodstream infections and is related to meaningful mortality specially, in pediatrics. Mortality rate range from 5% to 71%, and it can reach as high as 81%. Delays in beginning of treatment have also been linked to intensified mortality. The epidemiology of Candida infection is changing from region to region. Regiona...

To Vaccinate or Not to Vaccinate

To Vaccinate or Not to Vaccinate Hepatitis B virus infection is a disease that is associated with significant morbidity and mortality. Hepatitis D virus infection, which requires a coinfection with hepatitis B, is associated with an increased morbidity and mortality over that of hepatitis B virus infection alone. It is transmitted during sexual intercourse through contaminated body fluids, sali...